Human Anti-B. anthracis PA Recombinant Antibody (W2) (CAT#: HPAB-0748-YJ)

This product is a recombinant Chimeric (chimpanzee/human) antibody that recognizes Bacillus anthracis PA. It may serve as PA entry inhibitors for use in the emergency prophylaxis against and treatment of anthrax.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Published Data
  • Datasheet
  • MSDS
  • COA
ELISA

Figure 1 ELISA titration of anti–protective antigen (PA)

Figure 1 ELISA titration of anti–protective antigen (PA)

Recombinant PA or LF or unrelated proteins, bovine serum albumin (BSA), thyroglobulin, lysozyme, and phosphorylase b were used to coat the wells of an ELISA plate. Wells then were incubated with various dilutions of scFvs. Bound scFv was detected by the addition of peroxidase-conjugated anti-His antibody, followed by tetramethylbenzidine substrate. The anti-PA and antiLF scFvs did not bind to the unrelated proteins; only BSA is shown as an example. OD, optical density measured at 450 nm.

Chen, Z., Moayeri, M., Zhou, Y. H., Leppla, S., Emerson, S., Sebrell, A., ... & Purcell, R. (2006). Efficient neutralization of anthrax toxin by chimpanzee monoclonal antibodies against protective antigen. The Journal of infectious diseases, 193(5), 625-633.

Neut

Figure 2 In vitro neutralization assay.

Figure 2 In vitro neutralization assay.

Anti–protective antigen (PA) IgG was mixed with anthrax toxin and was incubated for 1 h at 37°C. The mixture was added to RAW264.7 cells in a 96-well plate and was incubated for 4 h at 37°C. After washing, the cells were stained with MTT dye, and then lysis was performed in a solution containing 0.5% SDS in 90% isopropanol and 0.05 mol/L HCl. The plate was read at an optical density measured at 570 nm, and the cell survival was calculated relative to untreated cells. Results were plotted and analyzed using Prism software (version 4; Graphpad Software). EC50, effective concentration for 50% neutralization. ■, W1; ▼, W2; □, 14B7.

Chen, Z., Moayeri, M., Zhou, Y. H., Leppla, S., Emerson, S., Sebrell, A., ... & Purcell, R. (2006). Efficient neutralization of anthrax toxin by chimpanzee monoclonal antibodies against protective antigen. The Journal of infectious diseases, 193(5), 625-633.

ELISA

Figure 3 Competitive ELISA.

Figure 3 Competitive ELISA.

Recombinant protective antigen (PA) was coated onto the wells of an ELISA plate. Wells then were incubated with anti-PA W2 Fab at the concentrations indicated. After incubation for 1 h at room temperature, anti-PA W2 Fab was removed from the wells, and mouse anti-PA monoclonal antibodies (MAbs) 14B7 and 2D3 were added to the wells. Bound MAbs were detected by the addition of peroxidase-conjugated anti–mouse antibody, followed by tetramethylbenzidine substrate. The binding to PA was calculated by dividing the optical density value in the absence of W2 by the optical density value in the presence of W2. ■, 14B7; ▲, 2D3.

Chen, Z., Moayeri, M., Zhou, Y. H., Leppla, S., Emerson, S., Sebrell, A., ... & Purcell, R. (2006). Efficient neutralization of anthrax toxin by chimpanzee monoclonal antibodies against protective antigen. The Journal of infectious diseases, 193(5), 625-633.

Inhib

Figure 4 Inhibition of the binding of protective antigen (PA) to RAW264.7 cells by preincubation of toxin with monoclonal antibodies.

Figure 4 Inhibition of the binding of protective antigen (PA) to RAW264.7 cells by preincubation of toxin with monoclonal antibodies.

PA at a concentration of 6 nmol/L (500 ng/mL) was incubated with antiPA 14B7 or W2 antibodies at a molar ratio of 1:1 or 1:10 for 5 min. The mixture was added to RAW264.7 cells and was incubated for 20 min at 37°C. After the cells were washed and lysed, separation by SDS-PAGE was performed. The proteins were transferred to a membrane and were probed with anti-PA polyclonal antibody.

Chen, Z., Moayeri, M., Zhou, Y. H., Leppla, S., Emerson, S., Sebrell, A., ... & Purcell, R. (2006). Efficient neutralization of anthrax toxin by chimpanzee monoclonal antibodies against protective antigen. The Journal of infectious diseases, 193(5), 625-633.


Specifications

  • Immunogen
  • Recombinant PA
  • Host Species
  • Human
  • Derivation
  • Chimeric (chimpanzee/human)
  • Type
  • Chimeric (chimpanzee/human) IgG1, κ
  • Specificity
  • B. anthracis
  • Species Reactivity
  • B. anthracis
  • Clone
  • W2
  • Applications
  • ELSIA, Neut
  • Related Disease
  • Anthrax

Product Property

  • Purity
  • >95% as determined by SDS-PAGE and HPLC analysis
  • Concentration
  • Please refer to the vial label for the specific concentration.
  • Buffer
  • PBS
  • Preservative
  • No preservatives
  • Storage
  • Centrifuge briefly prior to opening vial. Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Applications

  • Application Notes
  • This antibody has been tested for use in ELSIA, Neutralization. It's recommended that the optimal antibody concentration, dilution, incubition time, etc. be carefully titrated in specific assays.

Target

  • Alternative Names
  • Protective antigen; Bacillus anthracis

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Clone W2"

See other products for "B. anthracis PA"

Single-domain Antibody

CAT Product Name Application Type
NAB-194-VHH Recombinant Anti-B. anthracis PA VHH Single Domain Antibody WB, ICC, ChiP, FA, ELISA Llama VHH

Human Antibody

CAT Product Name Application Type
TAB-224 Anti-B. Anthracis Anthrax Protective Antigen (Raxibacumab) FC, IP, ELISA, Neut, FuncS, IF, WB IgG1 - lambda

Epitope-Specific Antibody

CAT Product Name Application Type
EPAF-0387LC Recombinant Mouse Anti-B. anthracis PA Antibody (F20G75) BL, ELISA IgG1

ADCC Enhanced Antibody

CAT Product Name Application Type
AFC-TAB-224 Afuco™ Anti-B. anthracis PA ADCC Recombinant Antibody (Raxibacumab), ADCC Enhanced FC, IP, ELISA, Neut, FuncS, IF ADCC enhanced antibody
AFC-TAB-440CQ Afuco™ Anti-PA ADCC Recombinant Antibody (Obiltoxaximab), ADCC Enhanced ELISA, IHC, FC, IP, IF, FuncS ADCC enhanced antibody

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for HPAB-0748-YJ. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare